Semaglutide and Tirzepatide are prescribed medications designed to aid in weight loss by mimicking hormones that regulate appetite and food intake. They work by reducing hunger, increasing feelings of fullness, and ultimately helping you achieve weight loss. Both medications are typically used alongside a balanced diet and exercise program for the best results. They offer effective support for individuals struggling with obesity or overweight, providing an additional tool in their weight management journey.
Semiglutide
Semaglutide mimics a hormone called GLP-1 (glucagon-like peptide-1) that helps regulate appetite and food intake by enhancing feelings of fullness and reducing hunger.
Clinical studies have shown that Semaglutide can lead to significant weight loss, with many individuals experiencing reductions of around 15-20% of their body weight.
Tirzepatide
Tirzepatide targets multiple hormone pathways, including GLP-1 and GIP (gastric inhibitory polypeptide), to control appetite and boost metabolism. This dual-action approach provides a more comprehensive impact on weight management.
Tirzepatide has demonstrated even greater weight loss potential compared to Semaglutide, with clinical trials showing reductions of around 20-25% of body weight in some patients.